Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

AGA releases new clinical guideline for diagnosing and managing gastroparesis

The American Gastroenterological Association (AGA) has released a new clinical guideline with 12 conditional recommendations for diagnosing and managing gastroparesis, a serious and often debilitating disease.

19 Sep 2025

Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.

Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.

19 Sep 2025

Hyperemesis gravidarum associated with increased neuropsychiatric disorders in pregnancy

The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes.

18 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

17 Sep 2025

New genetic test can help predict how people will respond to weight-loss medications

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.

17 Sep 2025

Lifestyle changes show promise in preventing cognitive decline and Alzheimer’s disease

An estimated 7.2 million Americans over age 65 currently live with Alzheimer's disease (AD). That number is expected to nearly double to 13.8 million by 2060.

16 Sep 2025

Study: Half of adults without diabetes taking weight-loss drug discontinue treatment within a year

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight.

15 Sep 2025

Ketogenic diets may lower migraine frequency and medication use

This narrative review argues that the migraine brain is hypometabolic, with converging evidence of mitochondrial dysfunction, impaired glucose handling, neuroinflammation, microbiome shifts, and obesity-related pathways. It proposes ketogenic diets as a plausible preventive strategy that may reduce monthly migraine days and medication use, while emphasizing the need for larger, rigorous randomized trials and careful clinical oversight.

14 Sep 2025

Why pregnant women struggle to follow healthy diets despite knowing what to eat

A UK study found that women trying to conceive, pregnant, or new mothers face major barriers to eating healthily, from fatigue and nausea to high food costs and generic advice. Support from family, personalized dietetic guidance, and co-created resources were highlighted as key facilitators.

9 Sep 2025

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), according to findings presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

8 Sep 2025

Why your playlist could be the key to reducing motion sickness

Scientists found that specific music genres can significantly reduce motion sickness, with joyful and soft music offering the most relief during travel.

5 Sep 2025

Extreme morning sickness found to carry heavy emotional and physical burden

A new study reveals the profound emotional and physical toll of extreme morning sickness, with more than half of affected women reporting they considered terminating their pregnancy, and 9 in 10 saying they had thought about not having more children.

3 Sep 2025

What are the benefits of chewing gum beyond oral health?

Chewing gum offers health benefits beyond oral care, enhancing performance and recovery, but research gaps for children and seniors need addressing.

29 Aug 2025

Illinois researchers highlight most effective nutritional approaches for GI distress in cancer care

Many modern cancer treatments are highly effective at reducing or eliminating tumors, but they can also cause severe gastrointestinal symptoms that impact patients' quality of life or lead to discontinuation of treatment.

28 Aug 2025

Engineering digital twins to transform diagnosis and treatment for GI disorders

For many people, gastrointestinal (GI) disorders are chronic and life-altering conditions. Yet despite their prevalence, doctors are often challenged by patients experiencing persistent symptoms with no way to accurately identify and diagnose diseases.

25 Aug 2025

Evidence review questions ketamine’s role in chronic pain treatment

A Cochrane review assessed ketamine and other NMDA receptor antagonists for chronic non-cancer pain. The evidence was low to very low certainty, showing no clear pain relief and potential adverse effects with intravenous ketamine.

21 Aug 2025

New nanoparticle system uses ultrasound to precisely deliver drugs

The trouble with many drugs is that they go where they shouldn't, producing unwanted side effects. Psychiatric drugs might cause dissociation, painkillers can induce nausea and chemotherapy often damages healthy cells.

18 Aug 2025

Nausea News and Research

Further Reading

Orforglipron pill improves heart and metabolic risk factors in trial

AGA releases new clinical guideline for diagnosing and managing gastroparesis

Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.

Hyperemesis gravidarum associated with increased neuropsychiatric disorders in pregnancy

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

New genetic test can help predict how people will respond to weight-loss medications

Lifestyle changes show promise in preventing cognitive decline and Alzheimer’s disease

Study: Half of adults without diabetes taking weight-loss drug discontinue treatment within a year

Ketogenic diets may lower migraine frequency and medication use

Why pregnant women struggle to follow healthy diets despite knowing what to eat

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

Why your playlist could be the key to reducing motion sickness

Extreme morning sickness found to carry heavy emotional and physical burden

What are the benefits of chewing gum beyond oral health?

Illinois researchers highlight most effective nutritional approaches for GI distress in cancer care

Engineering digital twins to transform diagnosis and treatment for GI disorders

Evidence review questions ketamine’s role in chronic pain treatment

New nanoparticle system uses ultrasound to precisely deliver drugs

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News